World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
13890
World Ranking
13066
National Ranking
930

Holger Hebart publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Holger Hebart sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 221 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Holger Hebart D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Holger Hebart sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Holger Hebart is affiliated with the University of Tübingen in Germany. Their research primarily spans the field of Medicine, with a focus on several specialized subfields such as Genetics, Oncology, Pathology and Forensic Medicine, Hematology, and Pulmonary and Respiratory Medicine.

The scientist's work addresses a range of topics, notably:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Advanced Breast Cancer Therapies
  • Chronic Myeloid Leukemia Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • COVID-19 and healthcare impacts

Holger Hebart has contributed to several publications appearing in prominent scientific journals. Frequent publication venues include:

  • Blood
  • HemaSphere
  • Hematological Oncology
  • International Journal of Cancer
  • Journal of Allergy and Clinical Immunology

Selected recent papers authored or co-authored by Holger Hebart include:

  • First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia, 2023, New England Journal of Medicine
  • Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study, 2023, The Lancet
  • Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany, 2020, Haematologica
  • High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations, 2023, Blood
  • A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial, 2021, Blood

Holger Hebart frequently collaborates with several co-authors, including:

  • Stephan Stilgenbauer
  • Barbara Eichhorst
  • Kirsten Fischer
  • Eugen Tausch
  • Michael Hallek

Best Publications

  • Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

    Hermann Einsele;Eddy Roosnek;Nathalie Rufer;Christian Sinzger

  • Detection and identification of fungal pathogens in blood by using molecular probes.

    H. Einsele;H. Hebart;G. Roller;J. Löffler

  • Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

    Einsele H;Ehninger G;Hebart H;Wittkowski Km

  • Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6-desaturation

    S.L Kelly;D.C Lamb;D.E Kelly;N.J Manning

  • Quantification of Fungal DNA by Using Fluorescence Resonance Energy Transfer and the Light Cycler System

    Juergen Loeffler;Norbert Henke;Holger Hebart;Diethard Schmidt

  • Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies

    Holger Hebart;Claudia Bollinger;Paul Fisch;Jacqueline Sarfati

  • Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Rüdiger Hehlmann;Michael Lauseker;Susanne Saußele;Markus Pfirrmann

  • Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome.

    C. Sinzger;K. Schmidt;J. Knapp;M. Kahl

  • Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.

    H Einsele;H Hebart;C Kauffmann-Schneider;C Sinzger

  • Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Sabine Mousset;Dieter Buchheidt;Werner Heinz;Markus Ruhnke

  • Early Detection of Aspergillus Infection after Allogeneic Stem Cell Transplantation by Polymerase Chain Reaction Screening

    Holger Hebart;Jürgen Löffler;Christof Meisner;François Serey

  • Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus.

    S. Riegler;H. Hebart;H. Einsele;P. Brossart

  • Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4.

    Sibylla Braedel;Markus Radsak;Hermann Einsele;Jean-Paul Latgé

  • Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease

    H Krause;H Hebart;G Jahn;C A Müller

  • Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

    Holger Hebart;Senay Daginik;Stefan Stevanovic;Ulrich Grigoleit

  • Contaminations Occurring in Fungal PCR Assays

    Juergen Loeffler;Holger Hebart;Ralf Bialek;Lars Hagmeyer

  • Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood.

    J Löffler;H Hebart;U Schumacher;H Reitze

  • Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains

    Jürgen Löffler;Steven L Kelly;Holger Hebart;Ulrike Schumacher

  • Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

    Susanne Saußele;Marie-Paloma Krauß;Rüdiger Hehlmann;Michael Lauseker

  • Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.

    Holger Hebart;Jürgen Löffler;Heike Reitze;Andreas Engel

Frequent Co-Authors

Hermann Einsele
Hermann Einsele University of Würzburg
Lothar Kanz
Lothar Kanz University of Tübingen
Gerhard Jahn
Gerhard Jahn University of Tübingen
Hartmut Döhner
Hartmut Döhner University of Ulm
Michael Hallek
Michael Hallek University of Cologne
Andreas Reiter
Andreas Reiter Heidelberg University
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Konstanze Döhner
Konstanze Döhner University of Ulm
Ernst Holler
Ernst Holler University of Regensburg
Jay S. Loeffler
Jay S. Loeffler Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens the door to a range of online degrees and diverse careers—including opportunities at the intersection of healthcare and technology. Graduates may find rewarding roles in the fast-growing field of medical coding, where knowledge of biological sciences is a strong asset.

It’s important to understand the differences in certification options, such as ccs vs cpc certification. Each pathway has unique requirements, costs, and benefits that affect career potential. For those considering this route, learning how much does a medical coder make can help in making an informed decision.

The medical coding job outlook is promising, with widespread demand across healthcare settings. If you’re interested in advancing your credentials, a bachelor's degree health information management program offers a flexible online option geared toward preparing students for leadership roles in health information.

Best Scientists Citing Holger Hebart

Trending Scientists

Recently Published Articles